Showing results (81-90 of 305) with videos related to

Sort By:
Pageof 31
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2010
Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantationLuisa Giaccone, Moreno Festuccia, Andrea Marengo, et al.
The Oncologist|January 13, 2006
A practical update on the use of bortezomib in the management of multiple myelomaJesús San Miguel, Joan Bladé, Mario Boccadoro, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Concurrent G-CSF and GM-CSF administration for the induction of bone marrow-derived cell mobilization in patients with acute myocardial infarction: a pilot study evaluating feasibility, safety and efficacySebastiano Marra, Paolo Scacciatella, Tullio Usmiani, et al.
Haematologica|June 21, 2006
Corticosteroids can reverse severe imatinib-induced hepatotoxicityDario Ferrero, Enrico Maria Pogliani, Giovanna Rege-Cambrin, et al.
European Journal of Haematology|March 8, 2006
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantationBenedetto Bruno, Roberto Sorasio, Patrizia Barozzi, et al.
Annals of Hematology|April 6, 2012
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myelomaGiovanni Barosi, Giampaolo Merlini, Atto Billio, et al.
Journal of Hematology & Oncology|August 10, 2016
Ruxolitinib in steroid refractory graft-vs.-host disease: a case reportEnrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.
Leukemia & Lymphoma|November 21, 2008
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesVittorio Montefusco, Francesca Gay, Francesco Spina, et al.
European Journal of Haematology|February 9, 2007
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myelomaMassimo Offidani, Sara Bringhen, Laura Corvatta, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|August 7, 2004
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myelomaAntonio Palumbo, Alessandra Bertola, Patrizia Falco, et al.
Pageof 31